Descripción

Extended analysis tables from the synbiotic IBS-D trial are presented as supplementary data from the peer review publication.

Figure 20

Source Paper

The Effectiveness of Synbiotic Preparation Containing Lactobacillus and Bifidobacterium Probiotic Strains and Short Chain Fructooligosaccharides in Patients with Diarrhea Predominant …

Nutrients (2020)

PMID: 32635661

DOI: 10.3390/nu12071999

Cite This Figure

![Figure 20: Extended analysis tables from the synbiotic IBS-D trial are presented as supplementary data from the peer review publication.]()

> Source: Barbara Skrzydło-Radomańska et al. "The Effectiveness of Synbiotic Preparation Containing Lactobacillus and Bifidoba." *Nutrients*, 2020. PMID: [32635661](https://pubmed.ncbi.nlm.nih.gov/32635661/)

<figure>
  <img src="" alt="Extended analysis tables from the synbiotic IBS-D trial are presented as supplementary data from the peer review publication." />
  <figcaption>Figure 20. Extended analysis tables from the synbiotic IBS-D trial are presented as supplementary data from the peer review publication.<br>  Source: Barbara Skrzydło-Radomańska et al. "The Effectiveness of Synbiotic Preparation Containing Lactobacillus and Bifidoba." <em>Nutrients</em>, 2020. PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/32635661/">32635661</a></figcaption>
</figure>

Evidencia relacionada

Bifidobacterium longum para Irritable Bowel Syndrome (IBS)

Calificación B · 4 estudios

Galactooligosaccharides (GOS) para Irritable Bowel Syndrome (IBS)

Calificación B · 3 estudios

Lactobacillus acidophilus para Irritable Bowel Syndrome (IBS)

Calificación B · 3 estudios

Fructooligosaccharides (FOS) para Irritable Bowel Syndrome (IBS)

Calificación D · 2 estudios